Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP635908.RAa1qlhqigJFOgMv4d_jC_azCP8KhePh0u-f0qevnuALk130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635908.RAa1qlhqigJFOgMv4d_jC_azCP8KhePh0u-f0qevnuALk130_provenance.
• NP896592.RAtpIGELkoNJOHsIGhPSuLLqTcuGdFAIbHbrNuc6paVP0130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896592.RAtpIGELkoNJOHsIGhPSuLLqTcuGdFAIbHbrNuc6paVP0130_provenance.
• NP509696.RASuYLGMWwVap42EvMUG8nYhT5mwEmiU_qajeFb_7zLy8130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509696.RASuYLGMWwVap42EvMUG8nYhT5mwEmiU_qajeFb_7zLy8130_provenance.
• NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_provenance.
• assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP263971.RAU4Q0YRafiVeoVhsTqzKqdBYZY0ZNcWLnI_YDgSbU4_k130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263971.RAU4Q0YRafiVeoVhsTqzKqdBYZY0ZNcWLnI_YDgSbU4_k130_provenance.
• NP509780.RAuMhIQ-oJE72VEhfiUCaNPBkr9Qg4SFS263569cSxjO4130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509780.RAuMhIQ-oJE72VEhfiUCaNPBkr9Qg4SFS263569cSxjO4130_provenance.
• NP509791.RAjDNrVQ1YgDEKA7yojd__fdI6N_RbNs45XtLfuaseJZY130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509791.RAjDNrVQ1YgDEKA7yojd__fdI6N_RbNs45XtLfuaseJZY130_provenance.
• NP509753.RA06bVcpXGOPNYdUQfKJZWDdsMXovg7eW_NMtdfRQ3R90130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509753.RA06bVcpXGOPNYdUQfKJZWDdsMXovg7eW_NMtdfRQ3R90130_provenance.
• NP263970.RAFVWCi1uam6I_0HKQ-I6LT3cvQM9nAabjkVKzpac6h_o130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263970.RAFVWCi1uam6I_0HKQ-I6LT3cvQM9nAabjkVKzpac6h_o130_provenance.
• NP263973.RAPp1u93G74yN-rNu5gE_cgTcE-sNAr5BiVTvR_eePLRU130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263973.RAPp1u93G74yN-rNu5gE_cgTcE-sNAr5BiVTvR_eePLRU130_provenance.
• NP263974.RAN1sZvI1w-xVXwMIDoWh-wAQqvw-YoL7vxxULjWx32P8130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263974.RAN1sZvI1w-xVXwMIDoWh-wAQqvw-YoL7vxxULjWx32P8130_provenance.